The CDK4/6-UCHL5-BRD4 axis confers resistance to BET inhibitors in MLL-rearranged leukemia cells by suppressing BRD4 protein degradation

Details 詳細情報について

• CRID

  1360294643740601984

• DOI

  10.1016/j.bbrc.2021.12.063

• ISSN

  0006291X

• Web Site

  https://api.elsevier.com/content/article/PII:S0006291X21016983?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S0006291X21016983?httpAccept=text/plain

• Data Source

  • Crossref
  • KAKEN